LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
114,900
+400 (0.35%)
May 30, 2025, 3:30 PM KST
81.23%
Market Cap 4.17T
Revenue (ttm) 146.42B
Net Income (ttm) 24.86B
Shares Out 36.28M
EPS (ttm) 673.51
PE Ratio 170.60
Forward PE 82.85
Dividend n/a
Ex-Dividend Date n/a
Volume 206,204
Average Volume 261,816
Open 115,300
Previous Close 114,500
Day's Range 114,100 - 117,200
52-Week Range 60,600 - 143,600
Beta 1.36
RSI 61.15
Earnings Date May 13, 2025

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 163
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.